LANNETT COMPANY, INC. (OTC Bulletin Board: LANN)
, a manufacturer of pharmaceutical products, announced that the Food and Drug Administration has approved the reformulated version of its existing abbreviated new drug application ("ANDA") for Diphenoxylate HCL and Atropine Sulfate Tablets USP, 2.5 mg/0.025 mg, a generic version of Searle's Lomotil, indicated for the management of diarrhea.
Lannett is currently working on approximately 15 new prescription product offerings. The company's current products serve a diverse range of medical treatments, including Attention-Deficit-Hyperactivity-Disorder, Pain Management, Irritable Bowel Syndrome, Allergies, Weight Management, Epilepsy, and AIDS. Lannett has approximately 80 employees and manufactures both prescription and over-the-counter generic drugs.
The Company's common stock trades in the over-the-counter market through the use of the inter-dealer "pink sheets" published by the National Quotations Bureau, Inc. under the symbol ("LANN"). For more information please call Larry Dalesandro at 215-333-9000.
SOURCE Lannett Company, Inc.
CONTACT: Franklin Dohanyos of Franklin Publicity, Inc., 248-399-1101, for Lannett Company, Inc.